(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.07%) $82.57
(0.79%) $2.05
(-0.50%) $2 345.80
(-1.05%) $27.37
(-0.31%) $958.50
(-0.19%) $0.933
(-0.35%) $10.99
(-0.54%) $0.796
(1.56%) $93.31
4 days till quarter result
(bmo 2024-05-03)
Expected move: +/- 13.17%
Live Chart Being Loaded With Signals
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas...
Stats | |
---|---|
Dagens volum | 1.22M |
Gjennomsnittsvolum | 1.57M |
Markedsverdi | 1.83B |
EPS | $0 ( 2024-03-01 ) |
Neste inntjeningsdato | ( $0.0900 ) 2024-05-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -12.38 |
ATR14 | $0.00700 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Konidaris Tasos | Buy | 87 720 | Class A Common Stock |
2024-03-12 | Konidaris Tasos | Sell | 30 790 | Class A Common Stock |
2024-03-12 | Konidaris Tasos | Sell | 87 720 | Restricted Stock Units |
2024-03-04 | Patel Chintu | Buy | 1 333 334 | Performance-Based Restricted Stock Units |
2024-03-04 | Patel Chintu | Buy | 370 370 | Restricted Stock Units |
INSIDER POWER |
---|
-8.45 |
Last 100 transactions |
Buy: 156 072 909 | Sell: 179 177 567 |
Volum Korrelasjon
Amneal Pharmaceuticals Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
ANAC | 0.962 |
AAC | 0.961 |
ESM-UN | 0.959 |
FTEV | 0.957 |
ACDI | 0.956 |
CPUH | 0.952 |
LII | 0.952 |
DMYS | 0.951 |
RCFA | 0.951 |
BCSF | 0.947 |
10 Mest negative korrelasjoner | |
---|---|
TU | -0.951 |
WEI | -0.95 |
NJR | -0.947 |
BCE | -0.945 |
WDH | -0.944 |
TLK | -0.944 |
NUS | -0.941 |
AHT-PD | -0.94 |
TIXT | -0.938 |
DTLA-P | -0.935 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Amneal Pharmaceuticals Korrelasjon - Valuta/Råvare
Amneal Pharmaceuticals Økonomi
Annual | 2023 |
Omsetning: | $2.39B |
Bruttogevinst: | $820.57M (34.28 %) |
EPS: | $-0.480 |
FY | 2023 |
Omsetning: | $2.39B |
Bruttogevinst: | $820.57M (34.28 %) |
EPS: | $-0.480 |
FY | 2022 |
Omsetning: | $2.21B |
Bruttogevinst: | $784.71M (35.47 %) |
EPS: | $-1.690 |
FY | 2021 |
Omsetning: | $2.09B |
Bruttogevinst: | $768.97M (36.73 %) |
EPS: | $0.0700 |
Financial Reports:
No articles found.
Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.